Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune deficiency syndrome (HIV infection)
Patent Number: 6184033
Date of First Priority Issue: Wednesday August 9th, 1995
Date Issued: Tuesday February 6th, 2001
Assignee: Centr Embrionalnikh Tkaney "Emcell" (Kiev, UA)
Inventor: Smikodub, Alexandr Ivanovich (Kiev, UA)
From Class: Use
Comments: No comments
This patent teaches the administration of fetal cells, including stem cells, for the treatment of HIV infection. Various stem cells are known to secrete anti-inflammatory compounds such as TGF-beta. One possible mechanism of action is that stem cells secrete these antiinflammatory compounds, which in turn inhibit NF-kappa B, which does not allow for the HIV to replicate.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.